Flexiquit+: Web Program to Promote Smoking Cessation in Sexual and Gender Minority Young Adult Smokers

Completed · Phase 1

Conditions studied: Tobacco Use Disorder

In brief

This phase I trial studies how well Flexiquit+ helps young adult smokers who identify as a sexual and/or gender minority to quit or cut down on smoking. Flexiquit+ is an avatar-led, web-based intervention that can help smokers quit or cut back on how much they smoke cigarettes and/or vape, reducing their chances of developing tobacco-related health conditions.

Key facts

Study ID

NCT04194918

Run by

Fred Hutchinson Cancer Center

People needed

25

Starts

2020-05-18

Expected to finish

2020-09-01

Last updated by the study team

2020-10-05

Who can join

Age: 18 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must self-identify as a sexual and/or gender minority (i.e., a sexual orientation other than straight and/or gender that doesn't match sex assigned at birth)
• Participants must currently reside in the United States and anticipate remaining in the United States for the duration of the study (2 months)
• Participants must self-report smoking at least 1 cigarette per day in the 30 days prior to screening
• Participants must self-report having at least weekly internet access for the next two months
• Participants must self-report being willing and able to stream video online for this study
• Participants must self-report current use of a personal email account
• Participants must self-report current use of text messaging
• Participants must self-report that they are interested in participating in the study for themselves (versus [vs] someone else)
• Participants must self-report that they are not currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program
• Participants must self-report that they have not participated in one of our prior smoking cessation studies, including the user-centered research conducted in the development of Flexiquit+
• Participants must self-report that they are comfortable reading, writing, and speaking English
• Participants must self-report that they understand and agree to the conditions of compensation
• Participants must self-report that they are not currently incarcerated in a prison
• Participants must be willing to use the Flexiquit+ program, complete the study assessments, and sign an online consent form

Where it is running

• Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.